DOI QR코드

DOI QR Code

The Financial Burden of Asthma: A Nationwide Comprehensive Survey Conducted in the Republic of Korea

  • Kim, Chang-Yup (Graduate School of Public Health, Seoul National University) ;
  • Park, Heung-Woo (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Ko, Su-Kyoung (Pfizer Korea Ltd.) ;
  • Chang, Suk-Il (Department of Internal Medicine, Sung-Ae Hospital) ;
  • Moon, Hee-Bom (Department of Internal Medicine, Ulsan University College of Medicine) ;
  • Kim, You-Young (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Cho, Sang-Heon (Department of Internal Medicine, Seoul National University College of Medicine)
  • Published : 2011.01.01

Abstract

Purpose: Asthma-related morbidity and mortality are increasing, and the financial burden imposed by this condition will substantially increase. Nevertheless, little information is available regarding the nature and magnitude of the burden due to asthma at the national level. This study was conducted to characterize the financial burden imposed by asthma in the Republic of Korea at the national level. Methods: The overall prevalence of asthma and the costs of related medical services were determined using data from the National Health Insurance Corporation, which is responsible for the National Health Insurance scheme. Indirect costs, including expenditures on complementary and alternative medicines, and the financial impact of an impaired quality of life (intangible costs) were estimated by surveying 660 asthmatics, and these estimates were transformed to the national level using the prevalence of asthma. Results: The prevalence of asthma and total costs related to the disease in 2004 were 4.19% and $2.04 billion, respectively. Direct costs and indirect costs contributed equally to total costs (46.9% and 53.1%, respectively). However, when intangible costs were included, total costs rose to $4.11 billion, which was equivalent to 0.44% of the national gross domestic product in 2004. Conclusions: The results provide evidence that asthma is a major health cost factor in the Republic of Korea and that intangible costs associated with asthma are significant cost drivers.

Keywords

References

  1. Mellis CM, Peat JK, Bauman AE, Woolcock AJ. The cost of asthma in New South Wales. Med J Aust 1991;155:522-8.
  2. Krahn MD, Berka C, Langlois P, Detsky AS. Direct and indirect costs of asthma in Canada, 1990. CMAJ 1996;154:821-31.
  3. Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 1999;13:281-6. https://doi.org/10.1034/j.1399-3003.1999.13b10.x
  4. Chew FT, Goh DY, Lee BW. The economic cost of asthma in Singapore. Aust N Z J Med 1999;29:228-33. https://doi.org/10.1111/j.1445-5994.1999.tb00688.x
  5. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 2000;106:493-9. https://doi.org/10.1067/mai.2000.109426
  6. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004;34:520-6. https://doi.org/10.1111/j.1365-2222.2004.1935.x
  7. Poulos LM, Toelle BG, Marks GB. The burden of asthma in children: an Australian perspective. Paediatr Respir Rev 2005;6:20-7. https://doi.org/10.1016/j.prrv.2004.11.004
  8. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996;9:636-42. https://doi.org/10.1183/09031936.96.09040636
  9. National Heart, Lung, and Blood Institute. Expert panel report 3: guidelines for the diagnosis and management of asthma [Internet]. Bethesda (MD): U.S. Dept. of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 2007 [updated 2007 Aug 28; cited 2010 Feb 1]. Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
  10. British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008;63 Suppl 4:iv1-121. https://doi.org/10.1136/thx.2008.097741
  11. Bielory L. Complementary and alternative interventions in asthma, allergy, and immunology. Ann Allergy Asthma Immunol 2004;93:S45-54. https://doi.org/10.1016/S1081-1206(10)61486-X
  12. Schafer T. Epidemiology of complementary alternative medicine for asthma and allergy in Europe and Germany. Ann Allergy Asthma Immunol 2004;93:S5-10. https://doi.org/10.1016/S1081-1206(10)61481-0
  13. Ernst E. Complementary therapies for asthma: what patients use. J Asthma 1998;35:667-71. https://doi.org/10.3109/02770909809048969
  14. Senna G, Passalacqua G, Crivellaro M, Bonadonna P, Gani F, Dorizzi R, Dama A, Canonica GW, Lombardi C. Unconventional medicine: a risk of undertreatment of allergic patients. Allergy 1999;54:1117-9.
  15. Kwon S. Payment system reform for health care providers in Korea. Health Policy Plan 2003;18:84-92. https://doi.org/10.1093/heapol/18.1.84
  16. World Health Organization. International classification of diseases [Internet]. [cited 2010 Feb 1] Available from: http://www.who.int/classifications/icd/en/.
  17. Global Initiative for Asthma. GINA Workshop Report. Global strategy for asthma management and prevention [Internet]. [cited 2010 Feb 1]. Available from: http://www.ginasthma.com.
  18. Park JW, Cho YS, Lee SY, Nahm DH, Kim YK, Kim DK, Sohn JW, Park JK, Jee YK, Cho YJ, Yoon HJ, Kim MK, Park HS, Choi BW, Choi IS, Park CS, Min KU, Moon HB, Park SH, Lee YK, Kim NS, Hong CS. Multi-center study for the utilization of quality of life questionnaire for adult Korean asthmatics (QLQAKA). J Asthma Allergy Clin Immunol 2000;20:467-80.
  19. Johannesson M, Jonsson B, Borgquist L. Willingness to pay for antihypertensive therapy--results of a Swedish pilot study. J Health Econ 1991;10:461-73. https://doi.org/10.1016/0167-6296(91)90025-I
  20. Central Intelligence Agency. The World Factbook 2010 - Korea, South [Internet]. [cited 2010 Sep 17]. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/ks.html.
  21. Kim YK, Kim SH, Tak YJ, Jee YK, Lee BJ, Park HW, Jung JW, Bahn JW, Chang YS, Choi DC, Chang SI, Min KU, Kim YY, Cho SH. High prevalence of current asthma and active smoking effect among the elderly. Clin Exp Allergy 2002;32:1706-12. https://doi.org/10.1046/j.1365-2222.2002.01524.x
  22. Peabody JW, Lee SW, Bickel SR. Health for all in the Republic of Korea: one country's experience with implementing universal health care. Health Policy 1995;31:29-42. https://doi.org/10.1016/0168-8510(94)00669-6
  23. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997;156:787-93. https://doi.org/10.1164/ajrccm.156.3.9611072
  24. Schafer T, Riehle A, Wichmann HE, Ring J. Alternative medicine in allergies - prevalence, patterns of use, and costs. Allergy 2002;57:694-700. https://doi.org/10.1034/j.1398-9995.2002.23469.x
  25. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998;80:189-94. https://doi.org/10.1016/S1081-1206(10)62954-7
  26. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999;141:1067-75. https://doi.org/10.1046/j.1365-2133.1999.03207.x
  27. Zillich AJ, Blumenschein K, Johannesson M, Freeman P. Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma. Pharmacoeconomics 2002;20:257-65. https://doi.org/10.2165/00019053-200220040-00004

Cited by

  1. How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases? vol.58, pp.6, 2011, https://doi.org/10.4166/kjg.2011.58.6.297
  2. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: Nationwide cross-sectional survey using complex sampling design vol.54, pp.7, 2011, https://doi.org/10.5124/jkma.2011.54.7.769
  3. Economic Costs for Adult Asthmatics According to Severity and Control Status in Korean Tertiary Hospitals vol.49, pp.3, 2011, https://doi.org/10.3109/02770903.2011.641046
  4. A Case of Brain Death Due to Asthma Exacerbation in a Noncompliant Patient with Refractory Asthma vol.83, pp.3, 2011, https://doi.org/10.3904/kjm.2012.83.3.411
  5. Educational demand on allergic diseases from 45 public health centers in Gyeonggi-do vol.1, pp.1, 2011, https://doi.org/10.4168/aard.2013.1.1.55
  6. Classification and Epidemiology of Allergic Rhinitis vol.85, pp.5, 2011, https://doi.org/10.3904/kjm.2013.85.5.445
  7. Epidemiology of allergic rhinitis in Korean children vol.1, pp.4, 2011, https://doi.org/10.4168/aard.2013.1.4.321
  8. Integrated traditional Chinese medicine for childhood asthma in Taiwan: a Nationwide cohort study vol.14, pp.None, 2011, https://doi.org/10.1186/1472-6882-14-389
  9. 부모의 특성을 포함한 아동기 천식과 아토피 피부염의 영향요인: 제5기 2차년도(2011년) 국민건강영양조사 자료를 중심으로 vol.21, pp.1, 2011, https://doi.org/10.4094/chnr.2015.21.1.20
  10. The development of patient-tailored asthma prediction model for the alarm system vol.4, pp.5, 2011, https://doi.org/10.4168/aard.2016.4.5.328
  11. Biomarkers of adult asthma and personalized medicine vol.4, pp.1, 2011, https://doi.org/10.4168/aard.2016.4.1.4
  12. 천식환자의 증상경험, 수면의 질 및 삶의 질에 관한 연구 vol.17, pp.11, 2016, https://doi.org/10.5762/kais.2016.17.11.616
  13. Asthma costs and social impact vol.3, pp.None, 2011, https://doi.org/10.1186/s40733-016-0029-3
  14. The impact of indoor air pollution on asthma vol.5, pp.6, 2017, https://doi.org/10.4168/aard.2017.5.6.312
  15. Impact of cognitive impairment on asthma control in older asthmatics vol.5, pp.1, 2017, https://doi.org/10.4168/aard.2017.5.1.34
  16. Allergen immunotherapy for the treatment of respiratory allergies in the elderly vol.17, pp.4, 2017, https://doi.org/10.1097/aci.0000000000000370
  17. Prevalence of Allergic Disease in Korean Adults: Results from the Korea National Health and Nutrition Examination Survey (2010–2012) vol.60, pp.10, 2017, https://doi.org/10.3342/kjorl-hns.2017.00185
  18. Changing patterns of adult asthma incidence: results from the National Health Insurance Service–National Sample Cohort (NHIS-NSC) database in Korea vol.8, pp.None, 2011, https://doi.org/10.1038/s41598-018-33316-y
  19. 제6기 국민건강영양조사 자료에 기초한 성인의 천식 유무에 따른 삶의 질 영향요인 vol.13, pp.3, 2011, https://doi.org/10.12811/kshsm.2019.13.3.127
  20. Chronic cough, not asthma, is associated with depression in the elderly: a community-based population analysis in South Korea vol.34, pp.6, 2019, https://doi.org/10.3904/kjim.2018.187
  21. Socioeconomic Burden of Disease Due to Asthma in South Korea vol.32, pp.4, 2020, https://doi.org/10.1177/1010539520920524
  22. Analysis of the Relationship between Asthma and Coffee/Green Tea/Soda Intake vol.17, pp.20, 2011, https://doi.org/10.3390/ijerph17207471
  23. Economic burden of asthma in Singapore vol.8, pp.1, 2011, https://doi.org/10.1136/bmjresp-2020-000654
  24. The economic burden of severe asthma in children: a comprehensive study vol.58, pp.11, 2011, https://doi.org/10.1080/02770903.2020.1802747